Omalizumab, sold under the trade name Xolair, is a humanized antibody originally designed to reduce sensitivity to inhaled or ingested allergens, especially in the control of moderate to severe allergic asthma, which does not respond to high doses of corticosteroids.
Send us your enquiry for Omalizumab. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Omalizumab email us and we will include your contribution on the website.